Euro Tech Holdings Company Limited (NASDAQ:CLWT – Get Free Report) was the recipient of a significant growth in short interest during the month of October. As of October 15th, there was short interest totaling 130,664 shares, a growth of 3,625.8% from the September 30th total of 3,507 shares. Based on an average daily volume of 6,372,151 shares, the days-to-cover ratio is presently 0.0 days. Approximately 8.4% of the shares of the stock are sold short.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded Euro Tech from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, September 25th. One research analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, Euro Tech has an average rating of “Hold”.
Read Our Latest Analysis on CLWT
Euro Tech Stock Performance
Shares of Euro Tech stock traded down $0.03 during trading hours on Tuesday, reaching $1.28. The company’s stock had a trading volume of 12,242 shares, compared to its average volume of 927,872. The firm has a 50 day moving average price of $1.51 and a 200-day moving average price of $1.38. Euro Tech has a one year low of $0.99 and a one year high of $2.68.
Euro Tech Company Profile
Euro Tech Holdings Company Limited, doing business as Euro Tech (NASDAQ: CLWT), is a Hong Kong-based distributor of water treatment equipment and analytical instruments. The company supplies products used in municipal and industrial water and wastewater treatment, as well as equipment for monitoring and analyzing water quality and industrial processes.
Its product offerings include water filtration and purification systems, membrane-related equipment, pumps, ultraviolet and ozone treatment systems, and laboratory and environmental testing instruments.
See Also
- Five stocks we like better than Euro Tech
- Analysts Turn Bullish on Meta Platforms Despite Post-Earnings Fall
- Approaching Earnings Season, Are Pure Play Quantum Stocks Still a Good Bet?
- Lockheed Martin’s F-35 Deal Could Change How Wall Street Values the Stock
- Merck and Moderna’s Cancer Vaccine Worked—Who Gets Paid?
Receive News & Ratings for Euro Tech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Euro Tech and related companies with MarketBeat.com's FREE daily email newsletter.
